• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALT
Click for more information
0.00% 0.5¢

ANALYTICA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Analytica Limited is engaged in the design, development and supply of Class I and II... Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ALT Underwritten Share Purchase PlanPRICE SENSITIVE27/09/13
ALT Investor Presentation27/09/13
ALT Share Purchase Plan Cleansing Notice27/09/13
ALT Trading HaltPRICE SENSITIVE25/09/13
ALT Appendix 4E and annual financial reportPRICE SENSITIVE30/08/13
ALT Release of Wise-Owl.com Research Report28/08/13
ALT Chinese patent granted for AutoStart Infusion SystemPRICE SENSITIVE14/08/13
ALT Investor Presentation12/08/13
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/07/13
ALT Investor presentation timetable30/07/13
ALT Shareholders Newsletter25/07/13
ALT Chinese Patent grantedPRICE SENSITIVE24/07/13
ALT Change in substantial holding24/07/13
ALT Change of Director's Interest Notice03/07/13
ALT Change of Director's Interest Notice14/06/13
ALT TAIWAN DISTRIBUTION AGREEMENT SIGNEDPRICE SENSITIVE07/06/13
ALT Trading HaltPRICE SENSITIVE05/06/13
ALT Receipt of R and D rebate30/05/13
ALT Letter of Intent -Taiwan DristributorPRICE SENSITIVE20/05/13
ALT Notice to Option Holders - expiry of options 6 June13/05/13
ALT Appendix 4C - quarterlyPRICE SENSITIVE30/04/13
ALT App 4D and Half Year financial reportPRICE SENSITIVE28/02/13
ALT SOUTH EAST ASIA MARKETING INITATIVEPRICE SENSITIVE21/02/13
ALT Appendix 4C - quarterlyPRICE SENSITIVE30/01/13
ALT Updated independent research report by WIse Owl20/12/12
ALT Brazilian Burette Distributor Letter of Intent SignedPRICE SENSITIVE18/12/12
ALT Appendix 3y's17/12/12
ALT Results of AGM28/11/12
ALT Operations Manager AGM Presentation28/11/12
ALT Chairmans address to the AGM28/11/12
ALT +FirstFlow Burette market updatePRICE SENSITIVE15/11/12
ALT Change in Registered Office01/11/12
ALT Share Trading Policy01/11/12
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/10/12
ALT Notice of Annual General Meeting/Proxy Form26/10/12
ALT Annual Report to shareholders26/10/12
ALT Company Secretary Appointment/Resignation15/10/12
ALT Full Year Statutory Accounts28/09/12
ALT Release of Wise-Owl.Com Research Report25/09/12
ALT Appendix 3B12/09/12
ALT Change in substantial holding07/09/12
ALT Change of Director's Interest Notice07/09/12
ALT Preliminary Final ReportPRICE SENSITIVE31/08/12
ALT Notice to ALTO Option Holders08/08/12
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/07/12
ALT Announces new Autostart Burette Production for US MarketPRICE SENSITIVE18/07/12
ALT +COMMENCEMENT OF SALES OF TUTA BURETTES WITH MEDIAFLUSH tm03/07/12
ALT Appendix 4CPRICE SENSITIVE30/04/12
ALT Change in substantial holding19/03/12
ALT Becoming a substantial holder16/03/12
ALT Change of Director's Interest Notice x 316/03/12
ALT Completion of Rights Issue12/03/12
ALT Appendix 3B12/03/12
ALT Half Yearly Report and AccountsPRICE SENSITIVE27/02/12
ALT Interim GuidancePRICE SENSITIVE10/02/12
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/01/12
ALT Details of Company Address24/01/12
ALT Company Secretary Appointment/Resignation23/12/11
ALT Change of Director's Interest Notice x 323/12/11
ALT Section 708A(5)(e) Notice22/12/11
ALT Appendix 3B22/12/11
ALT Rights Issue - undersubscriptions14/12/11
ALT Section 708A(5)(e) Notice06/12/11
ALT Appendix 3B06/12/11
ALT Appendix 3B01/12/11
ALT Release of Independent Research Report30/11/11
ALT Results of Meeting29/11/11
ALT Chairman's Address to Shareholders29/11/11
ALT Rights Issue - Extension of Offer Period28/11/11
ALT Entitlement and Acceptance Form16/11/11
ALT Letters to Shareholders- Rights Issue03/11/11
ALT Appendix 3B - Rights IssuePRICE SENSITIVE02/11/11
ALT Rights Issue ProspectusPRICE SENSITIVE02/11/11
ALT Appendix 3B02/11/11
ALT Option for Pelvic Floor Exercise System (Correction)PRICE SENSITIVE01/11/11
ALT Option to acquire patent for Pelvic Floor Exercise SystemPRICE SENSITIVE01/11/11
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/10/11
ALT Notice of Annual General Meeting/Proxy Form27/10/11
ALT Annual Report to shareholders27/10/11
ALT Full Year Statutory Accounts28/09/11
ALT Preliminary Final ReportPRICE SENSITIVE25/08/11
ALT Appendix 4C - quarterlyPRICE SENSITIVE29/07/11
ALT Final Director's Interest Notice25/07/11
ALT Initial Director's Interest Notice25/07/11
ALT Director Appointment/Resignation25/07/11
ALT +Supply Agreement - Concord Repatriation and General Hospital06/07/11
ALT +Supply Agreement for AnalyticaPRICE SENSITIVE06/07/11
ALT +Supply Agreement with NSW Ambulance ServicePRICE SENSITIVE12/05/11
ALT Appendix 4C - quarterlyPRICE SENSITIVE20/04/11
ALT Half Yearly Report and AccountsPRICE SENSITIVE28/02/11
ALT Price QueryPRICE SENSITIVE28/02/11
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/01/11
ALT Change in substantial holding23/12/10
ALT Securities Trading Policy21/12/10
ALT Results of Meeting18/11/10
ALT Operations Manager's AGM Presentation18/11/10
ALT Chairman's Address to Shareholders18/11/10
ALT Change in substantial holding08/11/10
ALT Appendix 4C Query LetterPRICE SENSITIVE05/11/10
ALT Appendix 4C - quarterlyPRICE SENSITIVE28/10/10
ALT Underwritten Share Purchase Plan
27/09/13PRICE SENSITIVE
ALT Investor Presentation
27/09/13
ALT Share Purchase Plan Cleansing Notice
27/09/13
ALT Trading Halt
25/09/13PRICE SENSITIVE
ALT Appendix 4E and annual financial report
30/08/13PRICE SENSITIVE
ALT Release of Wise-Owl.com Research Report
28/08/13
ALT Chinese patent granted for AutoStart Infusion System
14/08/13PRICE SENSITIVE
ALT Investor Presentation
12/08/13
ALT Appendix 4C - quarterly
31/07/13PRICE SENSITIVE
ALT Investor presentation timetable
30/07/13
ALT Shareholders Newsletter
25/07/13
ALT Chinese Patent granted
24/07/13PRICE SENSITIVE
ALT Change in substantial holding
24/07/13
ALT Change of Director's Interest Notice
03/07/13
ALT Change of Director's Interest Notice
14/06/13
ALT TAIWAN DISTRIBUTION AGREEMENT SIGNED
07/06/13PRICE SENSITIVE
ALT Trading Halt
05/06/13PRICE SENSITIVE
ALT Receipt of R and D rebate
30/05/13
ALT Letter of Intent -Taiwan Dristributor
20/05/13PRICE SENSITIVE
ALT Notice to Option Holders - expiry of options 6 June
13/05/13
ALT Appendix 4C - quarterly
30/04/13PRICE SENSITIVE
ALT App 4D and Half Year financial report
28/02/13PRICE SENSITIVE
ALT SOUTH EAST ASIA MARKETING INITATIVE
21/02/13PRICE SENSITIVE
ALT Appendix 4C - quarterly
30/01/13PRICE SENSITIVE
ALT Updated independent research report by WIse Owl
20/12/12
ALT Brazilian Burette Distributor Letter of Intent Signed
18/12/12PRICE SENSITIVE
ALT Appendix 3y's
17/12/12
ALT Results of AGM
28/11/12
ALT Operations Manager AGM Presentation
28/11/12
ALT Chairmans address to the AGM
28/11/12
ALT +FirstFlow Burette market update
15/11/12PRICE SENSITIVE
ALT Change in Registered Office
01/11/12
ALT Share Trading Policy
01/11/12
ALT Appendix 4C - quarterly
31/10/12PRICE SENSITIVE
ALT Notice of Annual General Meeting/Proxy Form
26/10/12
ALT Annual Report to shareholders
26/10/12
ALT Company Secretary Appointment/Resignation
15/10/12
ALT Full Year Statutory Accounts
28/09/12
ALT Release of Wise-Owl.Com Research Report
25/09/12
ALT Appendix 3B
12/09/12
ALT Change in substantial holding
07/09/12
ALT Change of Director's Interest Notice
07/09/12
ALT Preliminary Final Report
31/08/12PRICE SENSITIVE
ALT Notice to ALTO Option Holders
08/08/12
ALT Appendix 4C - quarterly
31/07/12PRICE SENSITIVE
ALT Announces new Autostart Burette Production for US Market
18/07/12PRICE SENSITIVE
ALT +COMMENCEMENT OF SALES OF TUTA BURETTES WITH MEDIAFLUSH tm
03/07/12
ALT Appendix 4C
30/04/12PRICE SENSITIVE
ALT Change in substantial holding
19/03/12
ALT Becoming a substantial holder
16/03/12
ALT Change of Director's Interest Notice x 3
16/03/12
ALT Completion of Rights Issue
12/03/12
ALT Appendix 3B
12/03/12
ALT Half Yearly Report and Accounts
27/02/12PRICE SENSITIVE
ALT Interim Guidance
10/02/12PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/01/12PRICE SENSITIVE
ALT Details of Company Address
24/01/12
ALT Company Secretary Appointment/Resignation
23/12/11
ALT Change of Director's Interest Notice x 3
23/12/11
ALT Section 708A(5)(e) Notice
22/12/11
ALT Appendix 3B
22/12/11
ALT Rights Issue - undersubscriptions
14/12/11
ALT Section 708A(5)(e) Notice
06/12/11
ALT Appendix 3B
06/12/11
ALT Appendix 3B
01/12/11
ALT Release of Independent Research Report
30/11/11
ALT Results of Meeting
29/11/11
ALT Chairman's Address to Shareholders
29/11/11
ALT Rights Issue - Extension of Offer Period
28/11/11
ALT Entitlement and Acceptance Form
16/11/11
ALT Letters to Shareholders- Rights Issue
03/11/11
ALT Appendix 3B - Rights Issue
02/11/11PRICE SENSITIVE
ALT Rights Issue Prospectus
02/11/11PRICE SENSITIVE
ALT Appendix 3B
02/11/11
ALT Option for Pelvic Floor Exercise System (Correction)
01/11/11PRICE SENSITIVE
ALT Option to acquire patent for Pelvic Floor Exercise System
01/11/11PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/10/11PRICE SENSITIVE
ALT Notice of Annual General Meeting/Proxy Form
27/10/11
ALT Annual Report to shareholders
27/10/11
ALT Full Year Statutory Accounts
28/09/11
ALT Preliminary Final Report
25/08/11PRICE SENSITIVE
ALT Appendix 4C - quarterly
29/07/11PRICE SENSITIVE
ALT Final Director's Interest Notice
25/07/11
ALT Initial Director's Interest Notice
25/07/11
ALT Director Appointment/Resignation
25/07/11
ALT +Supply Agreement - Concord Repatriation and General Hospital
06/07/11
ALT +Supply Agreement for Analytica
06/07/11PRICE SENSITIVE
ALT +Supply Agreement with NSW Ambulance Service
12/05/11PRICE SENSITIVE
ALT Appendix 4C - quarterly
20/04/11PRICE SENSITIVE
ALT Half Yearly Report and Accounts
28/02/11PRICE SENSITIVE
ALT Price Query
28/02/11PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/01/11PRICE SENSITIVE
ALT Change in substantial holding
23/12/10
ALT Securities Trading Policy
21/12/10
ALT Results of Meeting
18/11/10
ALT Operations Manager's AGM Presentation
18/11/10
ALT Chairman's Address to Shareholders
18/11/10
ALT Change in substantial holding
08/11/10
ALT Appendix 4C Query Letter
05/11/10PRICE SENSITIVE
ALT Appendix 4C - quarterly
28/10/10PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Tambourah chases gold veins and mineralisation extension with drilling Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.